LGND

Q: What is the price of Ligand Pharmaceuticals (LGND) today?

The price of Ligand Pharmaceuticals (LGND) today is $ 207.43, with return of 95.34% compared to the last year. The price of Ligand Pharmaceuticals (LGND) started the year trading around $ 189.07 and today it is at $ 207.43. Follow the real-time price chart, the historical price of Ligand Pharmaceuticals (LGND) and international markets.

Q: When does Ligand Pharmaceuticals (LGND) pay dividends?

Ligand Pharmaceuticals (LGND) did not distribute dividends in the last year.

Q: Is Ligand Pharmaceuticals (LGND) worth it?

Currently, Ligand Pharmaceuticals (LGND) is priced at $ 207.43, with a P/E of 30.98%, representing a deviation of -11,208% from its historical average P/E. In the last year, the stock showed a variation of 95.34 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 95.34%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Ligand Pharmaceuticals (LGND) stock?

Investing in stocks of Ligand Pharmaceuticals (LGND) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Ligand Pharmaceuticals (LGND) yield today?

The yield of Ligand Pharmaceuticals (LGND) was 12.84% in the last month, 95.34% in the last year and 33.97% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Ligand Pharmaceuticals (LGND) today, the total investment would be $ 20,743.00, based on the current price of $ 207.43.If past performance were to repeat, the return on your investment would be:In 1 year: $ 40,519.38In 5 years: $ 27,789.40In 10 years: $ 42,848.82It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Ligand Pharmaceuticals Incorporated

Price

$ 207.43

return (12m)

95.34%

p/e

30.98

p/bv

3.79

DIVIDEND YIELD

0.00%

LGND price

LGND

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment LGND

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

12.84%

3 months

7.68%

1 year

95.34%

2 years

191.79%

5 years

33.97%

10 years

106.57%

Fundamentals LGND

review the fundamentals of Ligand Pharmaceuticals shares

P/E

30.98

Sector: -3.84 Industry: -3.84

P/S (PSR)

14.38

Sector: -4.04 Industry: -4.04

P/BV

3.79

Sector: 1.96 Industry: 1.96

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

7.97%

Sector: -65.16% Industry: -65.16%

ROE

12.23%

Sector: -67.20% Industry: -67.20%

ROIC

8.16%

Sector: -1,301.95% Industry: -1,301.95%

NET MARGIN

46.42%

Sector: -41.23% Industry: -41.23%

GROSS MARGIN

94.57%

Sector: 38.75% Industry: 38.75%

OPERATING MARGIN

17.61%

Sector: -41.12% Industry: -41.12%

EV/EBITDA

32.52

Sector: -3.76 Industry: -3.76

EV/EBIT

44.97

Sector: -3.97 Industry: -3.97

PRICE-TO-ASSETS

2.47

Sector: 1.42 Industry: 1.42

BVPS

53.54

Sector: 1.79 Industry: 1.79

EPS

6.55

Sector: -2.04 Industry: -2.04

EQUITY-TO-ASSETS RATIO

0.65

Sector: 0.40 Industry: 0.40

LIABILITIES / ASSETS

0.35

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

-0.66%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

16.66%

Sector: - Industry: -

FAIR VALUE OF Ligand Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 207.43

Fair Value

$ 0.00

Upside/Downside Return potential.

-57.18%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LGND

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.71	7.34	33.81%	2.15%	$ 581.82 B	28.46%
PFE	19.45	1.62	8.35%	6.47%	$ 151.13 B	12.42%
ABBV	91.85	0.00	0.00%	3.03%	$ 388.17 B	6.91%
NVO	10.76	5.54	51.50%	4.45%	$ 168.58 B	33.05%
MRK	15.72	0.00	0.00%	2.84%	$ 286.94 B	28.08%
AZN	28.50	5.98	20.99%	1.67%	$ 291.40 B	17.41%
GILD	21.16	7.96	37.62%	2.18%	$ 180.08 B	28.90%
BMY	17.05	-3.53	-20.72%	4.21%	$ 120.29 B	14.64%
ZTS	18.95	15.20	80.25%	1.76%	$ 50.64 B	28.23%
REGN	17.05	2.46	14.41%	0.60%	$ 76.81 B	31.41%
HALO	23.71	153.90	649.21%	0.00%	$ 7.51 B	22.69%
AMGN	25.60	22.80	89.06%	2.64%	$ 197.39 B	20.98%
MCK	26.67	-1,169.01	-4,383.84%	0.33%	$ 115.73 B	1.09%
VRTX	30.16	6.39	21.18%	0.00%	$ 119.21 B	32.94%
CAH	30.82	-18.97	-61.56%	0.94%	$ 51.23 B	0.68%
ADMA	24.54	7.55	30.78%	0.00%	$ 3.61 B	28.80%
BIIB	20.64	1.46	7.08%	0.00%	$ 26.69 B	13.07%
HRMY	9.92	1.81	18.24%	0.00%	$ 1.57 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

LGND Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	04/05/2007	04/19/2007	15,00000000

ABOUT Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated

Average Investor10 user rating

4.0 (0 people)

United States

39 years

Founded: 1987

1995

Time since IPO - 31 years

115

Employees

The Company Ligand Pharmaceuticals Incorporated (United States), is listed on Nasdaq with a market value of $ 3.86 Billions, having an equity of $ 1.02 Billion.

With a total of 115 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 268.09 Millions, which generated a profit in the amount of $ 124.45 Millions.

As for its main indicators, the Company has a P/E ratio of 30.98, a P/BV ratio of 3.79 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker LGND.

Market cap

$ 3.86 Billions

Net worth

$ 1.02 Billion

US$ 1,017,210,000.00

Assets

$ 1.56 Billion

US$ 1,560,640,000.00

Total Shares Outstanding

19.00 Millions

19,000,000

Average Daily Trading Volume

$ 219.47 Thousand

US$ 219,472.00

Sector

Health Care

Industry

Biotechnology

LGND

LGND revenue and profits

Financial Results LGND

DRAG THE FRAME TO SEE MORE DATA

LGND cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 943.25 44,68% (12M)

P/E

26.67

0.33%

ROE

-4,383.84%

P/BV

-1,169.01

CAH - Cardinal Health

$ 217.59 69,84% (12M)

P/E

30.82

0.94%

ROE

-61.56%

P/BV

-18.97

JNJ - Johnson & Johnson

$ 243.19 53,50% (12M)

P/E

21.71

2.15%

ROE

33.81%

P/BV

7.34

PFE - Pfizer

$ 26.61 9,56% (12M)

P/E

19.45

6.47%

ROE

8.35%

P/BV

1.62

ABBV - AbbVie

$ 221.45 7,52% (12M)

P/E

91.85

3.03%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 115.43 27,29% (12M)

P/E

15.72

2.84%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 192.01 28,62% (12M)

P/E

28.50

1.67%

ROE

20.99%

P/BV

5.98

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 943.25 44,68% (12 M)

P/L

26.67

0.33%

ROE

-4,383.84%

P/VP

-1,169.01

CAH - Cardinal Health

$ 217.59 69,84% (12 M)

P/L

30.82

0.94%

ROE

-61.56%

P/VP

-18.97

JNJ - Johnson & Johnson

$ 243.19 53,50% (12 M)

P/L

21.71

2.15%

ROE

33.81%

P/VP

7.34

PFE - Pfizer

$ 26.61 9,56% (12 M)

P/L

19.45

6.47%

ROE

8.35%

P/VP

1.62

ABBV - AbbVie

$ 221.45 7,52% (12 M)

P/L

91.85

3.03%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 115.43 27,29% (12 M)

P/L

15.72

2.84%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 192.01 28,62% (12 M)

P/L

28.50

1.67%

ROE

20.99%

P/VP

5.98

Frequently Asked Questions

What is the price of Ligand Pharmaceuticals (LGND) today?

The price of Ligand Pharmaceuticals (LGND) today is $ 207.43, with return of 95.34% compared to the last year. The price of Ligand Pharmaceuticals (LGND) started the year trading around $ 189.07 and today it is at $ 207.43. Follow the real-time price chart, the historical price of Ligand Pharmaceuticals (LGND) and international markets.

When does Ligand Pharmaceuticals (LGND) pay dividends?

Ligand Pharmaceuticals (LGND) did not distribute dividends in the last year.

Is Ligand Pharmaceuticals (LGND) worth it?

Currently, Ligand Pharmaceuticals (LGND) is priced at $ 207.43, with a P/E of 30.98%, representing a deviation of -11,208% from its historical average P/E. In the last year, the stock showed a variation of 95.34 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 95.34%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Ligand Pharmaceuticals (LGND) stock?

Investing in stocks of Ligand Pharmaceuticals (LGND) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Ligand Pharmaceuticals (LGND) yield today?

The yield of Ligand Pharmaceuticals (LGND) was 12.84% in the last month, 95.34% in the last year and 33.97% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Ligand Pharmaceuticals (LGND) today, the total investment would be $ 20,743.00, based on the current price of $ 207.43.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 40,519.38
In 5 years: $ 27,789.40
In 10 years: $ 42,848.82

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

LGND

Ligand Pharmaceuticals Incorporated

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LGND

review the fundamentals of Ligand Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated

United States

39 years

1995

115

PROFIT X PRICE LGND

Financial Results LGND

LGND cash flow

Asset, Revenue and Profit Growth - LGND

LGND balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions